Rexahn Pharmaceuticals Board of Directors, Key People and Executives

Health Care & Life Sciences » Pharmaceuticals | Rexahn Pharmaceuticals Inc.

Rexahn Pharmaceuticals Inc. | Key People and Executives

Peter David Suzdak

Chief Executive Officer & Director

Peter C. Brandt

Chairman

Richard J. Rodgers

Independent Director

Kwang Soo Cheong

Independent Director

Charles G. Beever

Independent Director

Douglas J. Swirsky

President, Chief Financial Officer & Secretary

Peter David Suzdak

Chief Executive Officer & Director

Ely Benaim

Chief Medical Officer

Lisa M. Nolan

Chief Business Officer

Peter C. Brandt

Chairman

Richard J. Rodgers

Independent Director

Kwang Soo Cheong

Independent Director

Charles G. Beever

Independent Director

View Profile

Address	15245 Shady Grove Road Rockville Maryland 20850 United States
Employees	-
Website	http://www.rexahn.com
Updated	09/14/2018
Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems.